Wall Street Zen upgraded shares of Astera Labs (NASDAQ:ALAB – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday,Wall Street Zen reports.
ALAB has been the topic of several other reports. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Royal Bank Of Canada reduced their target price on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday. Weiss Ratings cut shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday, October 23rd. Morgan Stanley increased their price target on Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, BMO Capital Markets assumed coverage on Astera Labs in a research note on Thursday. They issued an “outperform” rating and a $375.00 price objective on the stock. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average target price of $320.85.
Read Our Latest Analysis on ALAB
Astera Labs Trading Up 6.3%
Shares of Astera Labs stock opened at $190.71 on Friday. The stock has a market cap of $33.33 billion, a PE ratio of 75.98 and a beta of 3.85. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48. The company’s 50-day moving average price is $300.46 and its two-hundred day moving average price is $255.80.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The company had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. During the same period in the prior year, the firm earned $0.49 earnings per share. The business’s quarterly revenue was up 153.6% on a year-over-year basis. On average, equities analysts predict that Astera Labs will post 2.71 EPS for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares in the company, valued at approximately $995,806.88. The trade was a 77.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 396,059 shares of company stock worth $123,408,470 in the last three months. 10.40% of the stock is owned by insiders.
Hedge Funds Weigh In On Astera Labs
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs during the 2nd quarter worth approximately $25,000. GK Wealth Management LLC bought a new stake in shares of Astera Labs during the 3rd quarter worth about $29,000. Archer Investment Corp acquired a new position in shares of Astera Labs in the second quarter valued at approximately $30,000. Signature Equity Partners LLC grew its holdings in Astera Labs by 1,680.0% in the 3rd quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock valued at $32,000 after buying an additional 84 shares in the last quarter. Finally, Whipplewood Advisors LLC increased its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after acquiring an additional 319 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.
Astera Labs News Roundup
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs reported Q3 revenue of $584.9 million, up 154% year over year, and its Scorpio switch business was highlighted as a major growth driver. One Seeking Alpha contributor upgraded the stock, citing Scorpio’s momentum and gross margins that may stabilize near 72%. Astera Labs: So Much To Like In Q3 (Upgrade)
- Positive Sentiment: BMO Capital initiated coverage with an Outperform rating and a $375 price target; Northland Securities also upgraded the stock to Outperform. These calls provide a counterpoint to recent selling and valuation worries. BMO Capital Initiates Coverage on Astera Labs With Outperform Rating Astera Labs Upgraded to Outperform at Northland Securities
- Neutral Sentiment: Analyst views remain divided, with one recent opinion arguing that the selloff may already reflect a potential growth slowdown in 2027. Astera Labs: Sell-Off Already Priced In 2027 Stall
- Negative Sentiment: A reported analyst downgrade triggered renewed pressure, while coverage also points to ALAB’s rich valuation after its Q3 results. Those concerns may amplify selling when technology stocks are broadly weak. Shares Gap Down After Analyst Downgrade Stock Drops After Q3 Results Spotlight Rich Valuation
- Negative Sentiment: Astera Labs was caught in a wider technology-sector selloff, adding market-wide pressure beyond company-specific news. Astera Labs Falls Amid Tech Selloff
About Astera Labs
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.
The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.
See Also
- Five stocks we like better than Astera Labs
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
